A new PCR test that identifies women with womb cancer from a sample taken from the cervix or vagina has been developed by researchers from UCL and the University of Innsbruck.
An international team including UCL and UCLH researchers have set out a framework to improve the integrity and quality of research using healthcare data.
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
Patients and the public are invited to an event on Saturday 24 September 2022 to learn about UCLH research in rheumatological conditions such as rheumatoid arthritis, lupus and gout.
A new type of MRI scan could help doctors diagnose prostate cancer more accurately and spare thousands of men harm from unnecessary biopsies, according to UCL research.